Status:
UNKNOWN
Impact of ctDNA in Cancer Early Detection and STAS Evaluation in Patients With GGOs
Lead Sponsor:
University of Roma La Sapienza
Conditions:
Lung Cancer
Spreading of Tumor
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is the early and non-invasive diagnosis of lung cancer in patients with pulmonary ground glass opacity. In particular, objective of the study is to evaluate the presence or absenc...
Eligibility Criteria
Inclusion
- age\> 18 years
- radiological finding of pulmonary ground glass opacity
- absence of solid or haematological tumor
Exclusion
- radio / chemotherapy treatment for at least 6 months
- patient unable to understand and express his consent to the study
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05187767
Start Date
April 1 2022
End Date
October 1 2024
Last Update
November 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thoracic Surgery Unit, Sapienza University of Rome
Roma, Italy